Added 2 days ago Drug news

Complete Response Letter from FDA for Evenity (romosozumab) as a treatment for postmenopausal women with osteoporosis. - Amgen +UCB.

Amgen and UCB announced that the FDA has issued a Complete Response Letter for the Biologics License Application (BLA) for...

Added 14 days ago Drug news

FDA approves Orencia (abatacept) for active Psoriatic Arthritis- BMS

The FDA has approved Orencia (abatacept), from BMS, for the treatment of adults with active Psoriatic Arthritis (PsA), a chronic,...

Added 16 days ago Drug news

FDA accepts for review the BLA for CT P10 biosimilar to Rituxan (rituximab).- Teva + Celltrion

Celltrion, Inc., a global biopharmaceutical company, and Teva Pharmaceutical Industries Ltd. announced that the FDA has accepted for review the...

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part II: analgesics and other drugs used in rheumatology practice

The objective of the guideline is to provide evidence-based recommendations, which do not imply a legal obligation, for clinicians to...

Added 1 year ago

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids

The objective of the guideline is to provide evidence-based recommendations, which do not imply a legal obligation, for clinicians when...

Added 1 year ago

EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice

A taskforce comprised of an expert group of 21 rheumatologists, radiologists and methodologists from 11 countries developed evidence-based recommendations on...

Added 2 years ago

Definitions of quality of life: what has happened and how to move on.

Quality of life (QOL) is an important outcome in spinal cord injury (SCI) rehabilitation, but it is unclear how to define and measure it.

Added 1 month ago

Lesinurad: A Review in Hyperuricaemia of Gout.

Lesinurad (Zurampic®) is an oral selective inhibitor of the URAT1 and OAT4 uric acid (UA) transporters of the kidney, via which it inhibits UA reabsorption and thus increases renal UA excretion and lowers serum UA (sUA) levels.

Added 1 month ago

Lesinurad: A significant advancement or just another addition to existing therapies of gout?

Gout is a metabolic disorder that usually presents as recurrent episodes of acute arthritis due to deposition of crystals in joints and cartilages. Despite the availability of several drugs for gout, its management is still less than adequate.

Added 1 month ago

Dose Optimization Study of Idelalisib in Follicular Lymphoma

This study will optimize the safety and efficacy of chronic administration of idelalisib in participants with follicular lymphoma (FL) and evaluate the overall safety profile of idelalisib...

Added 1 month ago

Inhibition of Co-Stimulation in Rheumatoid Arthritis (ICoSRA)

The purpose of this study is to use abatacept as a clinical molecular probe to evaluate the effects of inhibiting...

Added 2 years ago

A Study Comparing ABT-494 to Placebo and to Adalimumab in Subjects With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate (SELECT-COMPARE)

This is a phase 3, randomized, double-blind study comparing ABT-494 to Placebo and to Adalimumab in subjects with moderately to...

Added 2 years ago